aTyr Pharma Inc
SWB:471A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
aTyr Pharma Inc
SWB:471A
|
US |
|
W
|
Weichai Power Co Ltd
OTC:WEICF
|
CN |
|
V
|
Vector Ltd
XBER:VQA
|
NZ |
|
Sa Sa International Holdings Ltd
HKEX:178
|
HK |
|
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
US |
|
Franklin Financial Services Corp
NASDAQ:FRAF
|
US |
|
F
|
Facilities By ADF PLC
LSE:ADF
|
UK |
|
Centrica PLC
LSE:CNA
|
UK |
|
Tessenderlo Group NV
XBRU:TESB
|
BE |
|
J
|
Jyske Bank A/S
DUS:JYS1
|
DK |
|
S
|
Schloss Wachenheim AG
XHAM:SWA
|
DE |
|
Befesa SA
OTC:BFSAF
|
LU |
|
Boart Longyear Group Ltd
ASX:BLY
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 471A's stock price target?
Not Available
471A does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for aTyr Pharma Inc?
Projected CAGR
168%
The compound annual growth rate for Revenue over the next 8 years is 168%.